By comparison, DOX and nutlin treatment of the p53 wild-type liver cancer cell lines HepG2 and Sk-hep-1 also resulted in significant upregulation of PURPL, compared to the p53 null liver cancer cell line Hep3B (Fig. 3a + b; Supplementary Fig. S3g). This evidence concerns the gene TP53 and liver cancer.